Literature DB >> 2525379

Occurrence of a novel cardiac natriuretic peptide in rats.

H Itoh1, K Nakao, Y Kambayashi, K Hosoda, Y Saito, T Yamada, M Mukoyama, H Arai, G Shirakami, S Suga.   

Abstract

We established a specific radioimmunoassay for the ring structure of "iso-ANP" and detected iso-ANP[23-46]-like immunoreactivity (-LI) in the rat atrium (2.76 +/- 0.5 micrograms/g) and ventricle (13.9 +/- 5.7 ng/g). High performance-gel permeation chromatography revealed that iso-ANP[23-46]-LI in the rat heart was composed of two components with molecular weights of 10K and 5K. In reverse phase-high performance liquid chromatography, the retention times of these components were clearly different from that of synthetic iso-ANP. The 5K peptide was demonstrated to be present in the perfusate from isolated rat hearts and possessed binding ability to ANP receptors. This natriuretic peptide was, however, not detectable in other tissues including the brain. We conclude that the novel cardiac natriuretic peptide distinct from iso-ANP and ANP occurs in the rat heart and is secreted from the heart.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2525379     DOI: 10.1016/0006-291x(89)92661-2

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

1.  Ultracytochemical localization of particulate guanylate cyclase in rat adrenal gland exposed to stimulation by porcine brain natriuretic peptide.

Authors:  M G Rambotti; P Ercolani; A Spreca
Journal:  Histochem J       Date:  1993-05

2.  Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide.

Authors:  M Mukoyama; K Nakao; K Hosoda; S Suga; Y Saito; Y Ogawa; G Shirakami; M Jougasaki; K Obata; H Yasue
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

3.  Nonlinear mixed effect modeling of the pharmacodynamics of natriuretic peptides in rats.

Authors:  Y Hashimoto; S Mori; N Hama; K Nakao; H Imura; M Yamaguchi; M Yasuhara; R Hori
Journal:  J Pharmacokinet Biopharm       Date:  1993-06

4.  Responses of plasma concentrations of A type natriuretic peptide and B type natriuretic peptide to alacepril, an angiotensin-converting enzyme inhibitor, in patients with congestive heart failure.

Authors:  M Yoshimura; H Yasue; H Tanaka; K Kikuta; H Sumida; H Kato; M Jougasaki; K Nakao
Journal:  Br Heart J       Date:  1994-12

5.  Natriuretic peptide receptor mRNAs in the rat and human heart.

Authors:  D J Nunez; M C Dickson; M J Brown
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.